Aug 2026· Gels· Vol 12, pp. 722· 0 citations· 51 references
Medicine
TL;DR
This nanocomposite hydrogel integrating a bioactive carrier with a therapeutic payload to enable coordinated intervention across multiple phases of diabetic wound repair offers a promising strategy for the treatment of chronic diabetic wounds.
Abstract
(1) Background: Impaired diabetic wound healing stems from systemic dysregulation of the wound-healing cascade under hyperglycemic conditions, producing a disordered microenvironment marked by sustained inflammation, defective angiogenesis, and aberrant extracellular matrix remodeling, multifactorial, multistage pathological interactions demanding multi-target intervention. (2) Methods: We constructed a multifunctional nanocomposite hydrogel dressing (PGAs@CDV) based on a “drug-carrier integration” strategy, targeting the dysregulated hemostasis, inflammation, and proliferation phases of diabetic wound healing. An amphiphilic micelle carrier (PNO-GA) was synthesized by covalently conjugating Panax notoginseng oligosaccharide with gallic acid, loaded with Anemoside B4 to yield drug-loaded nanomicelles (PGAs), embedded into a carboxymethyl chitosan-dopamine-vanillin hydrogel (CDV) matrix to form PGAs@CDV. We then examined how PGAs@CDV affected diabetic wound healing. (3) Results: In vitro, PGAs@CDV enhanced cell migration and angiogenic capacity, exhibited potent antioxidant activity, and promoted M1-to-M2 macrophage polarization. We tested PGAs@CDV in a streptozotocin-induced diabetic mouse wound model. Wounds treated with PGAs@CDV closed faster than those treated with the control, CDV, PNO@CDV, and AB4@CDV. Four readouts tracked this difference: hemostasis was quicker, inflammation was lower, more blood vessels formed, and collagen deposition was higher. At the pathway level, PGAs@CDV suppressed NF-κB signaling and activated PI3K/AKT/HIF-1α. These two arms map onto the anti-inflammatory and pro-angiogenic effects observed above. (4) Conclusions: This nanocomposite hydrogel integrates a bioactive carrier with a therapeutic payload to enable coordinated intervention across multiple phases of diabetic wound repair. By combining structural support with sustained pharmacological activity, it offers a promising strategy for the treatment of chronic diabetic wounds.
In vivo, AP@EM-gel produced near-complete wound closure by day 14 and improved bacterial clearance, re-epithelialisation, collagen organisation, angiogenesis, and inflammatory resolution compared with the commercial dressing.
Rui Zhang, Suk-Fei Tan, Ye Wang et al.· Frontiers in Cell and Develo...· 0 citations
A novel 3D-printed PHSN composite scaffold is designed to regulate the immune microenvironment, establishing a strategy of synergistically modulating immunity, vascularization and bone formation, offering a promising and translatable solution for diabetic bone regeneration.
Ze-Cai Chen, P. Luo, Lei Qin et al.· Regenerative Biomaterials· 0 citations
The functions and mechanisms of the ALDH2@Lipo/EV-MN system are explored, providing a new strategy for the treatment of refractory diabetic wounds and promoting angiogenesis in vitro and alleviated oxidative damage and inflammation in macrophages.
Shaoyihan Fang, J. Min, Zhen-Zhen Chen et al.· Materials Today Bio· 0 citations
A multifunctional, mechanism-targeted strategy that provides a rational, disease-relevant approach for treating chronic diabetic wounds by dampening inflammatory signaling and protecting reparative cells is developed.
Yuefei Zhu, Na Yan, Yongqiang Xiao et al.· Small· 0 citations
A multi-functional dynamically responsive composite hydrogel with high-efficiency antioxidant, antibacterial, and pro-angiogenic capacities was fabricated and synergistically intervenes in multiple pathological links of diabetic wounds, overcomes several key limitations of existing dressings, and provides an innovative...
Yan-Ling Li, Yu-Han Mao, Jie Zhang et al.· Gels· 0 citations
It is demonstrated that this integrated system precisely remodels the pathological immune microenvironment, establishing a promising oligonucleotide-based therapeutic strategy for clinical diabetic wound regeneration.
Mei Zhang, Wen-Bin Yang, Xiao Fu et al.· Journal of Controlled Releas...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.